$GNPX
Genprex Inc

2019 Q3 Form 10-Q Financial Statement

#000143774919016579 Filed on August 13, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2019 Q2 2018 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.910M $3.200M $5.920M
YoY Change 11.7% -45.95% 448.15%
% of Gross Profit
Research & Development $467.3K $502.0K $113.0K
YoY Change -4.56% 344.41% 7.61%
% of Gross Profit
Depreciation & Amortization $3.437K $3.118K $1.171K
YoY Change 100.64% 166.27%
% of Gross Profit
Operating Expenses $467.3K $502.0K $113.0K
YoY Change -4.56% 344.41% 7.61%
Operating Profit -$2.381M -$3.704M -$6.036M
YoY Change 8.35% -38.64% 411.02%
Interest Expense $30.58K
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$2.380M -$3.700M -$6.060M
YoY Change 8.68% -38.94% 413.56%
Income Tax
% Of Pretax Income
Net Earnings -$2.376M -$3.695M -$6.061M
YoY Change 8.67% -39.03% 413.15%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$150.3K -$236.9K -$448.6K
COMMON SHARES
Basic Shares Outstanding 15.84M 13.90M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q3 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.550M $4.500M $12.00M
YoY Change -75.27% -62.5% 2453.19%
Cash & Equivalents $2.548M $4.497M $12.00M
Short-Term Investments
Other Short-Term Assets $260.0K $450.0K $540.0K
YoY Change -29.73% -16.67% 1700.0%
Inventory $800.0K $850.0K
Prepaid Expenses
Receivables $0.00 $10.00K $0.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.609M $5.802M $12.54M
YoY Change -66.24% -53.73% 2408.0%
LONG-TERM ASSETS
Property, Plant & Equipment $23.75K $24.37K $10.00K
YoY Change 48.51% 143.65% 0.0%
Goodwill
YoY Change
Intangibles $423.9K $421.5K $323.1K
YoY Change 30.43%
Long-Term Investments
YoY Change
Other Assets $435.7K $437.6K $336.6K
YoY Change 2078.28% 30.03% 52.98%
Total Long-Term Assets $459.4K $462.0K $350.9K
YoY Change 27.35% 31.65% -31.19%
TOTAL ASSETS
Total Short-Term Assets $3.609M $5.802M $12.54M
Total Long-Term Assets $459.4K $462.0K $350.9K
Total Assets $4.068M $6.264M $12.89M
YoY Change -63.18% -51.41% 1176.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $480.0K $880.0K $300.0K
YoY Change -15.79% 193.33% 76.47%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $60.00K $60.00K $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $537.2K $938.8K $300.5K
YoY Change -5.75% 212.36% 43.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $537.2K $938.8K $300.5K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $540.0K $940.0K $300.0K
YoY Change -5.26% 213.33% 42.86%
SHAREHOLDERS EQUITY
Retained Earnings -$38.05M -$35.68M -$24.21M
YoY Change 47.39%
Common Stock $15.84K $15.80K $13.90K
YoY Change 13.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.531M $5.325M $12.59M
YoY Change
Total Liabilities & Shareholders Equity $4.068M $6.264M $12.89M
YoY Change -63.18% -51.41% 1176.33%

Cashflow Statement

Concept 2019 Q3 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income -$2.376M -$3.695M -$6.061M
YoY Change 8.67% -39.03% 413.15%
Depreciation, Depletion And Amortization $3.437K $3.118K $1.171K
YoY Change 100.64% 166.27%
Cash From Operating Activities -$1.990M -$1.570M -$3.110M
YoY Change 35.37% -49.52% 364.18%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$40.00K -$20.00K
YoY Change -100.0% 100.0% 0.0%
Acquisitions
YoY Change
Other Investing Activities $50.00K -$850.0K
YoY Change
Cash From Investing Activities $40.00K -$890.0K -$20.00K
YoY Change -500.0% 4350.0% 0.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 15.11M
YoY Change -100.0% -100.0% 6469.57%
NET CHANGE
Cash From Operating Activities -1.990M -1.570M -3.110M
Cash From Investing Activities 40.00K -890.0K -20.00K
Cash From Financing Activities 0.000 0.000 15.11M
Net Change In Cash -1.950M -2.460M 11.98M
YoY Change 14.71% -120.53% -2704.35%
FREE CASH FLOW
Cash From Operating Activities -$1.990M -$1.570M -$3.110M
Capital Expenditures $0.00 -$40.00K -$20.00K
Free Cash Flow -$1.990M -$1.530M -$3.090M
YoY Change 36.3% -50.49% 375.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15842855
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock
CY2018Q1 gnpx Capital Stock Shares Authorized
CapitalStockSharesAuthorized
210000000
CY2018 gnpx Class Of Warrant Or Right Cancelled During Period
ClassOfWarrantOrRightCancelledDuringPeriod
15385
gnpx Class Of Warrant Or Right Cancelled During Period
ClassOfWarrantOrRightCancelledDuringPeriod
CY2018 gnpx Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
34615
gnpx Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
CY2018 gnpx Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
4.47
gnpx Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
gnpx Class Of Warrant Or Right Issued In Period
ClassOfWarrantOrRightIssuedInPeriod
0
CY2018 gnpx Class Of Warrant Or Right Issued In Period
ClassOfWarrantOrRightIssuedInPeriod
3166491
CY2019Q2 gnpx Investment Unit
InvestmentUnit
0
CY2018Q4 gnpx Investment Unit
InvestmentUnit
0
CY2018Q2 gnpx Nonvoting To Voting Common Stock Conversion Ratio
NonvotingToVotingCommonStockConversionRatio
1
CY2019Q2 gnpx Number Of Allowed Patents
NumberOfAllowedPatents
1
CY2019Q2 gnpx Number Of Patents
NumberOfPatents
32
gnpx Operating Lease Rent Expense Per Month
OperatingLeaseRentExpensePerMonth
2050
gnpx Payments To Acquire Research And Development Assets
PaymentsToAcquireResearchAndDevelopmentAssets
848706
gnpx Payments To Acquire Research And Development Assets
PaymentsToAcquireResearchAndDevelopmentAssets
CY2017Q4 gnpx Percentage Of Outstanding Shares For Warrant To Purchase Shares Of Common Stock
PercentageOfOutstandingSharesForWarrantToPurchaseSharesOfCommonStock
0.03
CY2010 gnpx Proceeds From State Of Texas Emerging Technology Fund Award
ProceedsFromStateOfTexasEmergingTechnologyFundAward
2250000
CY2011 gnpx Proceeds From State Of Texas Emerging Technology Fund Award
ProceedsFromStateOfTexasEmergingTechnologyFundAward
2250000
CY2019Q2 gnpx Research And Development Assets Current
ResearchAndDevelopmentAssetsCurrent
848706
CY2018Q4 gnpx Research And Development Assets Current
ResearchAndDevelopmentAssetsCurrent
0
CY2010Q4 gnpx State Of Texas Emerging Technology Fund Award Amount
StateOfTexasEmergingTechnologyFundAwardAmount
4500000
CY2019Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
877302
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
295069
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
40988042
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
38690586
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
46861
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3127563
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
330626
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1615896
CY2019Q2 us-gaap Assets
Assets
6263832
CY2019Q2 us-gaap Assets Current
AssetsCurrent
5801859
CY2018Q4 us-gaap Assets Current
AssetsCurrent
8847066
CY2019Q2 us-gaap Cash
Cash
4496542
CY2018Q4 us-gaap Cash
Cash
8600918
CY2018Q4 us-gaap Assets
Assets
9268956
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8600918
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
161251
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4496542
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12001535
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4104376
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11840284
CY2019Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2019Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
4266759
CY2018Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
8350918
CY2017Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
5.17
CY2018Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.60
CY2019Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.60
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
748060
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3864551
CY2019Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3864551
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15802855
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15239148
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15802855
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15239148
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
15803
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
15240
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
3703886
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
6036090
us-gaap Costs And Expenses
CostsAndExpenses
5874655
us-gaap Costs And Expenses
CostsAndExpenses
6722719
CY2019Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
16135
CY2018Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
18085
us-gaap Depreciation
Depreciation
6049
us-gaap Depreciation
Depreciation
2118
CY2019Q2 us-gaap Depreciation
Depreciation
3118
CY2018Q2 us-gaap Depreciation
Depreciation
1171
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.53
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.21
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2013Q4 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2500000
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.38
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3198728
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5921950
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4858524
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6556011
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2018 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
582233
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-328535
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1444
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8844
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-759591
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
1950
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-13411
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-31290
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
209019
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
515137
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
421473
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
379451
CY2019Q2 us-gaap Interest Expense
InterestExpense
CY2018Q2 us-gaap Interest Expense
InterestExpense
30584
us-gaap Interest Expense
InterestExpense
us-gaap Interest Expense
InterestExpense
37982
us-gaap Interest Paid Net
InterestPaidNet
us-gaap Interest Paid Net
InterestPaidNet
10645
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
8646
CY2018Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
5461
us-gaap Investment Income Interest
InvestmentIncomeInterest
20569
us-gaap Investment Income Interest
InvestmentIncomeInterest
5489
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6263832
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9268956
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
938764
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
387821
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15187463
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-896788
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-33093
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3207588
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3314086
us-gaap Net Income Loss
NetIncomeLoss
-5854086
us-gaap Net Income Loss
NetIncomeLoss
-6755212
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-694001
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-6061213
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-2158846
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-3695240
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3703886
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6036090
us-gaap Operating Income Loss
OperatingIncomeLoss
-5874655
us-gaap Operating Income Loss
OperatingIncomeLoss
-6722719
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
9600000
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
437608
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
397536
CY2019Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
61462
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
92752
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
42022
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
24570
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6060
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8523
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
445870
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
236851
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15389353
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24365
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24354
CY2019Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
10741
CY2018Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
9297
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
201890
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
502040
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
112969
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1010082
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
164590
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-35678777
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29824691
CY2019Q2 us-gaap Revenues
Revenues
CY2018Q2 us-gaap Revenues
Revenues
us-gaap Revenues
Revenues
us-gaap Revenues
Revenues
us-gaap Share Based Compensation
ShareBasedCompensation
2298019
us-gaap Share Based Compensation
ShareBasedCompensation
3527656
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
127593
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
91813
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
91813
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2034525
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1461715
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4535681
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5905583
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2628749
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.31
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.31
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.94
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.21
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.60
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y324D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y302D
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
213707
CY2018 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
200009
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
351376
CY2018 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
553303
CY2018Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
176650
CY2018Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
176650
CY2019Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
192396
CY2019Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
159101
CY2018Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
CY2018Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15389288
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
428574
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-41915
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
12590373
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
8881135
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
7245311
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
5325068
CY2018Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
6.6841954
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The preparation of our condensed financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div>
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15622886
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13507942
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15480122
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12636316

Files In Submission

Name View Source Status
0001437749-19-016579-index-headers.html Edgar Link pending
0001437749-19-016579-index.html Edgar Link pending
0001437749-19-016579.txt Edgar Link pending
0001437749-19-016579-xbrl.zip Edgar Link pending
ex_147950.htm Edgar Link pending
ex_147951.htm Edgar Link pending
ex_147952.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gnpx-20190630.xml Edgar Link completed
gnpx-20190630.xsd Edgar Link pending
gnpx-20190630_cal.xml Edgar Link unprocessable
gnpx-20190630_def.xml Edgar Link unprocessable
gnpx-20190630_lab.xml Edgar Link unprocessable
gnpx-20190630_pre.xml Edgar Link unprocessable
gnpx20190331b_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending